Novabridge Biosciences (NBP) Directors and Executive Officers - CSIMarket
CSIMarket
 
Novabridge Biosciences  (NBP)

Novabridge Biosciences

Officers & Directors


Wei Fu, age 43, has served as Executive Chairman of the Board of Directors since September 2025 and has been a board member since June 2018. He is also the CEO of CBC Group, a healthcare-focused private equity firm. Emmett T. Cunningham, Jr., M.D., Ph.D., MPH, age 65, has been Vice Chairman of the Board of Directors since February 2026. He previously held positions as Senior Managing Director at The Blackstone Group and leadership roles at Clarus Ventures, Eyetech Pharmaceuticals, and Pfizer Inc. Chun Kwok Alan Au, age 53, has been an Independent Director since January 2020. He is the founder and managing partner of GT Healthcare and has prior experience with Deutsche Bank Group, JAFCO Asia Investment Group, and Morningside Group. He also serves on the boards of CSPC Pharmaceutical Group and TJ Biopharma.








NBP Management Effectiveness NBP Revenue per Employee NBP Income per Employee


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.